מאמרים

Fecal transplant for recurrent Clostridium difficile infection in children with and without inflammatory bowel disease

Russell GH, Kaplan JL, Youngster I, Baril-Dore M, Schindelar L, Hohmann E, Winter HS

J Pediatr Gastroenterol Nutr 2014 May;58(5):588-92

Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study

Youngster I, Sauk J, Pindar C, Wilson RG, Kaplan JL, Smith MB, Alm EJ, Gevers D, Russell GH, Hohmann EL. Clin Infect Dis. 2014 Jun;58(11):1515-22

Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients

Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A, Aroniadis O, Barto A, Borody T, Giovanelli A, Gordon S, Gluck M, Hohmann EL, Kao D, Kao JY, McQuillen DP, Mellow M, Rank KM, Rao K, Ray A, Schwartz MA, Singh N, Stollman N, Suskind DL, Vindigni SM, Youngster I, Brandt L

Am J Gastroenterol 2014 Jul;109(7):1065-71

Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection

Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL

JAMA. 2014 Nov 5;312(17):1772-8. doi: 10.1001/jama.2014.13875. Erratum in: JAMA. 2015 Feb 17;313(7):729

Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection

Youngster I, Mahabamunuge J, Systrom HK, Sauk J, Khalili H, Levin J, Kaplan JL, Hohmann EL

BMC Med 2016 Sep 9;14(1):134

Editorial: Making Fecal Microbiota Transplantation Easier to Swallow: Freeze-Dried Preparation for Recurrent Clostridium difficile Infections

Youngster I, Gerding DN

Am J Gastroenterol 2017 Jun;112(6):948-950

Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation

Smillie CS, Sauk J, Gevers D, Friedman J, Sung J, Youngster I, Hohmann EL, Staley C, Khoruts A, Sadowsky MJ, Allegretti JR, Smith MB, Xavier RJ, Alm EJ.

Cell Host Microbe 2018 Feb 14;23(2):229-240.e5

THE EPIDEMIOLOGY OF CLOSTRIDIUM DIFFICILE INFECTIONS AND ASPECTS PERTAINING TO TREATMENT WITH VANCOMYCIN AT ASSAF HAROFEH MEDICAL CENTER

Youngster I, Lazarovitch T, Bondorenco M, Kachlon Y, Toledano L, Mengesha B, Zaidenstein R, Daniel C, Dadon M, Marchaim D

Harefuah 2018 May;157(5):305-308 Hebrew

Five years of fecal microbiota transplantation - an update of the Israeli experience

Greenberg SA, Youngster I, Cohen NA, Livovsky DM, Strahilevitz J, Israeli E, Melzer E, Paz K, Fliss-Isakov N, Maharshak N

World J Gastroenterol. 2018 Dec 21;24(47):5403-5414

Potential impact of removing metronidazole from treatment armamentarium of mild acute Clostridioides difficile infection

Zilberman-Itskovich S, Youngster I, Lazarovitch T, Bondarenco M, Toledano L, Kachlon Y, Mengesha B, Strul N, Zaidenstein R, Marchaim D

Future Microbiol. 2019 Nov;14:1489-1495